LUND, Sweden--(BUSINESS WIRE)--Regulatory News:
BioInvent International AB (OMXS: BINV) today announces that it has been granted a US patent for its antibody and concomitant target discovery technology F.I.R.S.T.™.
Help employers find you! Check out all the jobs and post your resume.
